BCR Signaling in Chronic Lymphocytic Leukemia and Related Inhibitors Currently in Clinical Studies

ISSN： 0883-0185

Source： International Reviews of Immunology, Vol.32, Iss.4, 2013-08, pp. : 358-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis in Chronic Lymphocytic Leukemia

Current Angiogenesis, Vol. 2, Iss. 2, 2013-09 ,pp. : 96-103

Bentham Science Publishers

Access to resources Recommend Favorite

The prognostic value of clinical and laboratory parameters in patients with chronic lymphocytic leukemia

By Nenova I. Mateva N. Ananoshtev N. Grudeva-Popova J.

Hematology, Vol. 10, Iss. 1, 2005-02 ,pp. : 47-51

Maney Publishing

Access to resources Recommend Favorite

Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab–bendamustine

By García-Muñoz Ricardo García Diana Roldán-Galiacho Verónica Merchante-Andreu Miriam Campeny-Najara Andrea Rabasa Pilar

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 699-702

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Pathogenesis of Chronic Lymphocytic Leukemia

Current Molecular Medicine, Vol. 6, Iss. 6, 2006-09 ,pp. : 665-675

Bentham Science Publishers

Access to resources Recommend Favorite

B-Cell Antigen Receptor Signaling in Chronic Lymphocytic Leukemia: Therapeutic Targets and Translational Opportunities

By Hill Ronald J.

International Reviews of Immunology, Vol. 32, Iss. 4, 2013-08 ,pp. : 377-396

Informa Healthcare

Access to resources Recommend Favorite